Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
IACP Member Alert: FDA Addresses Questions for the Record (QFR)
Share |

The Food & Drug Administration (FDA) has sent their responses to the Questions for the Record submitted by U.S. Representative Morgan Griffith (R-VA). IACP's questions regarding Office Use are included on pages 41-43.


Please click here to view FDA's responses.


In a September 15th letter to Representatives Griffith, Green and DeGette, the Food & Drug Administration (FDA) clearly stated it is interpreting 503A to only permit the compounding of prescriptions for individual patients. This is in direct contradiction to Congressional intent as included in several "Statements of the Record" from Senators and Congressmen that nothing in the Drug Quality & Security Act was intended to interfere with state authority over the practice of pharmacy.


Please click here to view FDA's letter.


Please read IACP's Capitol Connections member newsletter, distributing Friday, September 19th, for more information.

Association Management Software Powered by YourMembership  ::  Legal